|
Immunotherapy
Citations 71-80 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Immunologic and functional evidence for anti–Siglec-9 autoantibodies in intravenous immunoglobulin preparations
- Stephan von Gunten, Alexander Schaub, Monique Vogel, Beda M. Stadler, Sylvia Miescher, and Hans-Uwe Simon
Blood 2006; 108: 4255-4259.
[Abstract]
[Full text]
[PDF]
Continuous in vivo infusion of interferon-gamma (IFN- ) enhances engraftment of syngeneic wild-type cells in Fanca–/– and Fancg–/– mice
- Yue Si, Samantha Ciccone, Feng-Chun Yang, Jin Yuan, Daisy Zeng, Shi Chen, Henri J. van de Vrugt, John Critser, Fre Arwert, Laura S. Haneline, and D. Wade Clapp
Blood 2006; 108: 4283-4287.
[Abstract]
[Full text]
[PDF]
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent
- Luca Gattinoni, Anju Ranganathan, Deborah R. Surman, Douglas C. Palmer, Paul A. Antony, Marc R. Theoret, David M. Heimann, Steven A. Rosenberg, and Nicholas P. Restifo
Blood 2006; 108: 3818-3823.
[Abstract]
[Full text]
[PDF]
Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide
- Katja Mauerer Zirlik, David Zahrieh, Donna Neuberg, and John G. Gribben
Blood 2006; 108: 3865-3870.
[Abstract]
[Full text]
[PDF]
T lymphocytes redirected against the  light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells
- Juan Vera, Barbara Savoldo, Stephane Vigouroux, Ettore Biagi, Martin Pule, Claudia Rossig, Jessie Wu, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, and Gianpietro Dotti
Blood 2006; 108: 3890-3897.
[Abstract]
[Full text]
[PDF]
CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells
- Dominic F. Kelly, Mathew D. Snape, Elizabeth A. Cutterbuck, Sarah Green, Claire Snowden, Linda Diggle, Ly-mee Yu, Astrid Borkowski, E. Richard Moxon, and Andrew J. Pollard
Blood 2006; 108: 2642-2647.
[Abstract]
[Full text]
[PDF]
Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab
- Julie A. Bowles, Siao-Yi Wang, Brian K. Link, Barrett Allan, Gregory Beuerlein, Mary-Ann Campbell, David Marquis, Brian Ondek, James E. Wooldridge, Brian J. Smith, James B. Breitmeyer, and George J. Weiner
Blood 2006; 108: 2648-2654.
[Abstract]
[Full text]
[PDF]
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab
- Rhona Stein, Zhengxing Qu, Susan Chen, David Solis, Hans J. Hansen, and David M. Goldenberg
Blood 2006; 108: 2736-2744.
[Abstract]
[Full text]
[PDF]
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor
- Patrick P. Ng, Gustavo Helguera, Tracy R. Daniels, Simon Z. Lomas, Jose A. Rodriguez, Gary Schiller, Benjamin Bonavida, Sherie L. Morrison, and Manuel L. Penichet
Blood 2006; 108: 2745-2754.
[Abstract]
[Full text]
[PDF]
Thymosin  1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance
- Luigina Romani, Francesco Bistoni, Katia Perruccio, Claudia Montagnoli, Roberta Gaziano, Silvia Bozza, Pierluigi Bonifazi, Giovanni Bistoni, Guido Rasi, Andrea Velardi, Francesca Fallarino, Enrico Garaci, and Paolo Puccetti
Blood 2006; 108: 2265-2274.
[Abstract]
[Full text]
[PDF]
|
|
